XM does not provide services to residents of the United States of America.
T
T

TransDigm

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Acuity Brands, CSG Systems International, Nuvation Bio

U.S. RESEARCH ROUNDUP-Acuity Brands, CSG Systems International, Nuvation Bio March 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acuity Brands, CSG Systems International, and Nuvation Bio, on Wednesday. HIGHLIGHTS * Acuity Brands Inc AYI.N : Baird raises target price to $286 from $236 * CSG Systems International CSGS.O : RBC initiates coverage with outperform rating * Lenz Therapeutics Inc LENZ.O : Piper Sandler
N
V
D
T
I
M

U.S. Evercommerce, Immuneering, Ulta Beauty

U.S. RESEARCH ROUNDUP-Evercommerce, Immuneering, Ulta Beauty March 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Evercommerce, Immuneering and Ulta Beauty, on Friday. HIGHLIGHTS * Berry Global Group Inc BERY.N : RBC cuts to sector perform from outperform * Evercommerce Inc EVCM.O : JP Morgan cuts to underweight from neutral * Immuneering Corp IMRX.O : TD Cowen cuts to market perform from outperform * Sunrun Inc
A
H
L
M
M
U
L
T
B

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Energia, Springer Nature, Shift4 Payments; Updates TransDigm, Direct Line Feb 28 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2045 GMT on Wednesday: * * Fiserv FI.N and Amadeus IT Group AMA.MC are competing to acquire Shift4 Payments FOUR.N , a payments processor that has a market value of nearly $7 billion, according to people familiar with the matter.
A
A
C
K
S
V
D
T

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: TransDigm, Kuwait Finance House, Ageas, Reliance Industries, SCB X, A Updates: Swisscom Feb 28 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT, on Wednesday: ** Britain approved TransDigm's TDG.N acquisition of U.S.-based Communications & Power Industries (CPI), subject to the condition that CPI's UK research and manufacturing capabilities in relation to atomic clocks remain in the country.
A
C
K
S
V
D
T

UK approves TransDigm-CPI deal with national security condition

UPDATE 1-UK approves TransDigm-CPI deal with national security condition Adds comment from statement in paragraph 2, background throughout LONDON, Feb 28 (Reuters) - Britain on Wednesday approved TransDigm's TDG.N acquisition of units owned by U .S.-based Communications & Power Industries (CPI), on the condition that CPI's UK research and manufacturing capabilities in relation to atomic clocks remain in the country.
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.